Derivative exercise or conversion — not an open-market buy.
Traded Dec 1, 2025 · Filed Dec 2, 2025
A board member of Bruker sold $243K of Bruker shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$243,230
Shares × reported transaction price
28 days after results of Nov 3, 2025, 42 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.0% | +0.5% | −2.5% |
| 30 days | +0.5% | −0.1% | +0.6% |
| 90 days | −17.9% | −0.5% | −17.4% |
| 180 days | +22.1% | +10.9% | +11.2% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.